Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03763942 · ClinicalTrials.gov registry record · NA

HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)

A NA study of HIV Infections, sponsored by Emory University.

Completed
Registry status
NA
Development phase
658
Enrollment target
3
Study locations

NCT03763942 is a NA study of HIV Infections that has completed, run by Emory University. The registered enrollment target is 658 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (48% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03763942, a NA study of HIV Infections, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
658 participants
Enrollment target
3
Study locations

Study Summary

This study is a randomized controlled clinical trial of a theoretically based mobile app, HealthMindr, to increase pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV). Participants in the intervention arm will receive access to the HealthMindr app, with information about PrEP and other HIV prevention methods in addition to provider locators. Participants randomized to the control arm will receive standard of care. The primary aim for this study is to assess PrEP uptake in the intervention arm compared to the control arm.

Conditions Studied

HIV Infections

Interventions

  • BEHAVIORAL HealthMindr App
  • BEHAVIORAL Control App

Study Locations (3)

District of Columbia

  • George Washington University - Washington D.C.

Georgia

  • Emory University - Atlanta

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 658 participants
Start Date 2020-01-28
Est. Completion 2023-03-17
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03763942

The ClinicalTrials.gov registry entry for NCT03763942 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 658 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (48% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which HealthMindr App is the first listed.

NCT03763942 reports 3 study locations spanning 3 distinct geographic areas - top geographies include District of Columbia, Georgia, Mississippi.

Frequently Asked Questions

What is clinical trial NCT03763942 about?

NCT03763942 is a clinical study titled "HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)". This study is a randomized controlled clinical trial of a theoretically based mobile app, HealthMindr, to increase pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV). Participants in the intervention arm will receive access to t...

What is the current status of trial NCT03763942?

This trial is currently completed. It is a NA study. The enrollment target is 658 participants. The study started on 2020-01-28. Estimated completion is 2023-03-17.

What conditions does trial NCT03763942 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT03763942?

The interventions under investigation include: HealthMindr App (BEHAVIORAL), Control App (BEHAVIORAL).

Who is sponsoring clinical trial NCT03763942?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03763942 being conducted?

This trial has 3 study locations across District of Columbia, Georgia, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.